Response to aflibercept in patients with fibrovascular pigment epithelial detachment refractory to ranibizumab in exudative age-related macular degeneration

被引：1
作者：
Tran, T. H. C. [1 ]
Dumas, S. [2 ]
Coscas, F. [3 ,4 ]
机构：
[1] Univ Catholique Lille, Grp Hop Catholique Lille, Serv Ophtalmol, Blvd Belfort,BP 387, F-59020 Lille, France
[2] Clin Louviere, F-59042 Lille, France
[3] Ctr Ophtalmol Odeon, F-75006 Paris, France
[4] Univ Paris Est Creteil, Ctr Hosp Intercommunal Creteil, Creteil, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2017年 / 40卷 / 03期
关键词：
ANTI-VEGF THERAPY; NEOVASCULAR AMD; BEVACIZUMAB;
D O I：
10.1016/j.jfo.2016.11.007
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E99 / E101
页数：3
相关论文
共 8 条
  • [1] Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
    Binder, Susanne
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (01) : 1 - 2
  • [2] Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
    Fassnacht-Riederle, Heidi
    Becker, Matthias
    Graf, Nicole
    Michels, Stephan
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (11) : 1705 - 1709
  • [3] Maringe E, 2016, J FR OPHTALMOL
  • [4] Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
    Martin, Daniel F.
    Maguire, Maureen G.
    Ying, Gui-shuang
    Grunwald, Juan E.
    Fine, Stuart L.
    Jaffe, Glenn J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) : 1897 - 1908
  • [5] Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration
    Messenger, Wyatt B.
    Campbell, J. Peter
    Faridi, Ambar
    Shippey, Loton
    Bailey, Steven T.
    Lauer, Andreas K.
    Flaxel, Christina J.
    Hwang, Thomas S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) : 1205 - 1207
  • [6] Patel KH, 2013, EYE
  • [7] A single-arm, investigator-initiated study of the efficacy, safety and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration, previously treated with ranibizumab or bevacizumab: 6-month interim analysis
    Singh, Rishi P.
    Srivastava, Sunil
    Ehlers, Justis P.
    Bedi, Rumneek
    Schachat, Andrew P.
    Kaiser, Peter K.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 : 22 - 27
  • [8] Response to Aflibercept After Frequent Re-treatment With Bevacizumab or Ranibizumab in Eyes With Neovascular AMD
    Thorell, Mariana R.
    Nunes, Renata Portella
    Chen, Gene W.
    Doshi, Rishi R.
    Dugar, Jyoti
    George, Mathew K.
    Kim, Brian T.
    Lowrance, Matthew D.
    Modi, Dimple
    Nahas, Zayna
    Gregori, Giovanni
    Yehoshua, Zohar
    Feuer, William
    Rosenfeld, Philip J.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (06) : 526 - 533
1